Environmental Contamination and Persistence of Clostridioides difficile in Hospital Wastewater Systems.


Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
31 05 2023
Historique:
medline: 2 6 2023
pubmed: 19 4 2023
entrez: 18 4 2023
Statut: ppublish

Résumé

Clostridioides difficile produces an environmentally resistant dormant spore morphotype that infected patients shed to the hospital environment. C. difficile spores persist in clinical reservoirs that are not targeted by hospital routine cleaning protocols. Transmissions and infections from these reservoirs present a hazard to patient safety. This study aimed to assess the impact of patients acutely suffering from C. difficile-associated diarrhea (CDAD) on C. difficile environmental contamination to identify potential reservoirs. Twenty-three hospital rooms accommodating CDAD inpatients with corresponding soiled workrooms of 14 different wards were studied in a German maximum-care hospital. Additionally, four rooms that never accommodated CDAD patients were examined as negative controls. Stagnant water and biofilms from sinks, toilets, and washer disinfector (WD) traps as well as swabs from cleaned bedpans and high-touch surfaces (HTSs) were sampled. For detection, a culture method was used with selective medium. A latex agglutination assay and a Tox A/B enzyme-linked immunosorbent assay were performed with suspect colonies. Stagnant water and biofilms in hospital traps (29%), WDs (34%), and HTSs (37%) were found to be reservoirs for large amounts of C. difficile during the stay of CDAD inpatients that decreased but could persist 13 ± 6 days after their discharge (13%, 14%, and 9.5%, respectively). Control rooms showed none or only slight contamination restricted to WDs. A short-term cleaning strategy was implemented that reduced C. difficile in stagnant water almost entirely.

Identifiants

pubmed: 37071016
doi: 10.1128/aem.00014-23
pmc: PMC10231184
doi:

Substances chimiques

Wastewater 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0001423

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Infect Dis. 1981 Jan;143(1):42-50
pubmed: 7217711
Infect Control Hosp Epidemiol. 2009 Oct;30(10):939-44
pubmed: 19715426
Infect Control Hosp Epidemiol. 2009 Jan;30(1):25-33
pubmed: 19046054
J Clin Microbiol. 2015 Aug;53(8):2570-4
pubmed: 26041892
Commun Med (Lond). 2022 Jun 1;2:62
pubmed: 35664456
Arch Intern Med. 2002 Jul 8;162(13):1483-92
pubmed: 12090885
Int J Hyg Environ Health. 2019 Apr;222(3):455-467
pubmed: 30622005
Infect Control Hosp Epidemiol. 2018 Nov;39(11):1307-1315
pubmed: 30284524
Appl Environ Microbiol. 2019 Jan 9;85(2):
pubmed: 30367005
Antimicrob Agents Chemother. 2015 Jan;59(1):714-6
pubmed: 25348541
J Clin Microbiol. 1983 Aug;18(2):348-52
pubmed: 6619285
Front Microbiol. 2016 Oct 26;7:1698
pubmed: 27833595
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):484-501
pubmed: 32215678
Infect Control Hosp Epidemiol. 2014 Jan;35(1):10-5
pubmed: 24334792
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
Water Res. 2020 Jun 1;176:115707
pubmed: 32224328
J Hosp Infect. 2012 Sep;82(1):19-24
pubmed: 22841682
J Hosp Infect. 2001 Nov;49(3):204-9
pubmed: 11716638
Antimicrob Resist Infect Control. 2017 Feb 16;6:24
pubmed: 28239453
J Hosp Infect. 2008 Oct;70(2):198-9
pubmed: 18723244
Nat Commun. 2013;4:2601
pubmed: 24131955
Emerg Infect Dis. 2012 Aug;18(8):1242-7
pubmed: 22841005
Water Res. 2019 Feb 1;149:640-649
pubmed: 30594003
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):906-923
pubmed: 31236653
Am J Infect Control. 2008 Feb;36(1):5-11
pubmed: 18241730
J Hosp Infect. 2012 Oct;82(2):122-4
pubmed: 22871394
Clin Microbiol Infect. 2013 Nov;19(11):E490-8
pubmed: 23829434
Pediatr Infect Dis J. 2012 Jul;31(7):685-90
pubmed: 22466324
Curr Opin Infect Dis. 2003 Aug;16(4):343-7
pubmed: 12861087
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1211-1221
pubmed: 30945014
Acta Paediatr. 2015 Aug;104(8):e344-9
pubmed: 25772515
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Sep;59(9):1189-220
pubmed: 27558147
Am J Infect Control. 2007 Jun;35(5):315-8
pubmed: 17577478
Appl Environ Microbiol. 2017 Mar 31;83(8):
pubmed: 28235877
J Hosp Infect. 2022 Apr;122:140-147
pubmed: 35077809
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30249685
J Hosp Infect. 2008 Feb;68(2):171-7
pubmed: 18192076
Infect Control Hosp Epidemiol. 2011 Jul;32(7):687-99
pubmed: 21666400
Am J Infect Control. 2017 Aug 1;45(8):844-848
pubmed: 28526314
FEMS Immunol Med Microbiol. 2012 Jul;65(2):183-95
pubmed: 22444301
J Appl Microbiol. 2008 Dec;105(6):2223-30
pubmed: 19120667
Antimicrob Agents Chemother. 2007 Aug;51(8):2883-7
pubmed: 17562803
Int J Hyg Environ Health. 2019 May;222(4):655-662
pubmed: 30905579
GMS Krankenhhyg Interdiszip. 2007 Sep 13;2(1):Doc19
pubmed: 20200680
J Hosp Infect. 2016 Oct;94(2):169-74
pubmed: 27485396

Auteurs

Lia Freier (L)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Nicole Zacharias (N)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Stefanie Gemein (S)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.
Reference Institute for Bioanalytics, Bonn, Germany.

Jürgen Gebel (J)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Steffen Engelhart (S)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Martin Exner (M)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Nico T Mutters (NT)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH